Anemia with elevation of growth differentiation factor-15 level in linezolid treated multidrug-resistant tuberculosis: Case series of three patients

2018 Leader, 2018, Linezolid-induced pancytopenia, Case Rep Patel, 2012, Toxicity assessment of linezolid and the beneficial effects of human erythropoietin in mice, Eur J Exp Biol, 2, 2172 Fujita, 2016, Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age‐related disorders, Geriatr Gerontol Int, 16, 17, 10.1111/ggi.12724 Wollert, 2017, Growth differentiation factor 15 as a biomarker in cardiovascular disease, Clin Chem, 63, 140, 10.1373/clinchem.2016.255174 Sotgiu, 2012, Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis, Eur Respir J, 40, 1430, 10.1183/09031936.00022912 Shi, 2003, Mechanisms of TGF-β signaling from cell membrane to the nucleus, Cell, 113, 685, 10.1016/S0092-8674(03)00432-X Ago, 2006, GDF15, a cardioprotective TGF-β superfamily protein, Am Heart Assoc, 98, 294 Liu, 2015, Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma, PLOS One, 10, 10.1371/journal.pone.0127518 Soriano, 2005, Mitochondrial toxicity associated with linezolid, N Engl J Med, 353, 2305, 10.1056/NEJM200511243532123 Garrabou, 2007, Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia, Antimicrob Agents Chemother, 51, 962, 10.1128/AAC.01190-06 Behar, 2011, Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis, Mucosal Immunol, 4, 279, 10.1038/mi.2011.3 Leach, 2007, The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria, Mol Cell, 26, 393, 10.1016/j.molcel.2007.04.005 Nair, 2017, Growth differentiation factor–15 and risk of CKD progression, J Am Soc Nephrol, 28, 2233, 10.1681/ASN.2016080919 Welsh, 2003, Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum, Proc Natl Acad Sci USA, 100, 3410, 10.1073/pnas.0530278100 Fine-Coulson, 2015, Infection of A549 human type II epithelial cells with Mycobacterium tuberculosis induces changes in mitochondrial morphology, distribution and mass that are dependent on the early secreted antigen, ESAT-6, Microbes Infect, 17, 689, 10.1016/j.micinf.2015.06.003 Mann, 2021, Candidate biomarkers to distinguish spinal tuberculosis from mechanical back pain in a tuberculosis endemic setting, Front Immunol, 12, 10.3389/fimmu.2021.768040 Theurl, 2010, Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia, Br J Haematol, 148, 449, 10.1111/j.1365-2141.2009.07961.x Tanno, 2010, Growth differentiation factor 15 in erythroid health and disease, Curr Opin Hematol, 17 Banaszkiewicz, 2020, Evaluating the relationship of GDF-15 with clinical characteristics, cardinal features, and survival in multiple myeloma, Mediat Inflamm, 10.1155/2020/5657864 Przybyłowski, 2014, Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure Ueland, 2021, Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF, Clin Res Cardiol, 1 Nalado, 2020, Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa, BMC Nephrol, 21, 1, 10.1186/s12882-020-02046-7